Related Experiment Video
Updated: Dec 24, 2025
09:29
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
18.7K
Metabolic Reprogramming in Triple-Negative Breast Cancer
Xiangyu Sun1, Mozhi Wang1, Mengshen Wang1
1Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
Frontiers in Oncology
|April 17, 2020
Summary
Cancer cells reprogram metabolism to fuel growth. Understanding metabolic reprogramming in triple-negative breast cancer (TNBC) offers new therapeutic targets to combat aggressive tumors, metastasis, and chemoresistance.
Area of Science:
- Oncology
- Cancer Metabolism
Background:
- Metabolic reprogramming is a key hallmark of cancer, enabling proliferation and progression.
- Triple-negative breast cancer (TNBC) is aggressive, with poor prognosis and high recurrence rates despite chemotherapy.
- TNBC exhibits chemoresistance and metastasis, contributing to high mortality.
Purpose of the Study:
- To discuss metabolic reprogramming in TNBC.
- To explore how TNBC cells adapt metabolically to nutrient-poor environments.
- To investigate the role of metabolic adaptation in TNBC metastasis and chemoresistance.
Main Methods:
- Review of current literature on cancer metabolism and TNBC.
- Analysis of metabolic phenotypes in TNBC cells and their microenvironment.
- Focus on metabolic adaptations driving metastasis and chemoresistance.
Main Results:
- TNBC cells exhibit distinct metabolic phenotypes to support proliferation.
- Metabolic reprogramming allows TNBC cells to survive in nutrient-poor conditions.
- Metabolic adaptations are crucial for TNBC metastasis and chemoresistance.
Conclusions:
- Metabolic reprogramming presents promising therapeutic targets for TNBC.
- Targeting metabolic vulnerabilities could improve outcomes for TNBC patients.
- Further research into TNBC metabolic adaptations is needed for novel drug development.
Related Concept Videos
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
03:03mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
01:14Introduction to Nuclear Reprogramming
2.2K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.2K
02:53Adaptive Mechanisms in Cancer Cells
6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K